1. Bronchospasm Secondary to Replacement Estrogen Therapy
Lynell C. Collins, M.D., F.C.C.P, Alan Peiris, M.D. 
CHEST 
Volume 104, Issue 4, Pages (October 1993)
DOI: /chest
Copyright © 1993 The American College of Chest Physicians Terms and Conditions

2. FIGURE 1
A, Peak expiratory flow rate (PEFR) at baseline, during estrogen treatment, and after termination of estrogen treatment. Although this is an effort-dependent test, the patient reliably reproduced each measurement on three separate attempts. Each point represents the best of three efforts made near 10 AM daily. B, Forced expiratory volume in 1 s (FEV1) at baseline and during estrogen treatment. Before repeat pulmonary function testing could be performed, the patient suffered myocardial infarction and died from complications.
CHEST  , DOI: ( /chest )
Copyright © 1993 The American College of Chest Physicians Terms and Conditions